Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374758 · ClinicalTrials.gov registry record · Phase 4
Accelerated ART Initiation for PWHIV Who Are Out of Care
A Phase 4 study of HIV Infections and ART, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT06374758 is a Phase 4 study of HIV Infections and ART that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 120 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (73% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT06374758, a Phase 4 study of HIV Infections and ART, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
Conditions Studied
Interventions
- OTHER The Accelerate model of care
- DRUG bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg
Study Locations (4)
Missouri
- University of Missouri-Columbia - Columbia
- KC Care Health Center - Kansas City
- AIDS Project of the Ozarks - Springfield
- NOVUS Health - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2026-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06374758
The ClinicalTrials.gov registry entry for NCT06374758 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (73% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which The Accelerate model of care is the first listed.
NCT06374758 reports 4 study locations spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06374758 about?
NCT06374758 is a clinical study titled "Accelerated ART Initiation for PWHIV Who Are Out of Care". The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a...
What is the current status of trial NCT06374758?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2024-04-29. Estimated completion is 2026-11-01.
What conditions does trial NCT06374758 study?
This clinical trial studies the following conditions: HIV Infections, ART, Noncompliance, Patient.
What interventions are being tested in trial NCT06374758?
The interventions under investigation include: The Accelerate model of care (OTHER), bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg (DRUG).
Who is sponsoring clinical trial NCT06374758?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374758 being conducted?
This trial has 4 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
RECRUITING · Phase 4
-
PrEP Intervention for People Who Inject Substances and Use Methamphetamine
RECRUITING · Phase 4
-
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
COMPLETED · Phase 4
-
"The Once A Day Protease Inhibitor Regimens"
COMPLETED · Phase 4
-
Buprenorphine and Integrated HIV Care
COMPLETED · Phase 4
-
Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.